Matsui et al. identified high expression of CNCNA1C in calcified valves and verified the involvement of CACNA1C in CAVD progression by affecting valve calcification in VIC cells [33]. The gene discussed is CACNA1C; the disease is congenital bilateral aplasia of vas deferens from CFTR mutation.